ArticleBiomedical materials & devices (New York, N.Y.)2025
Monitoring the Residual Limb-Socket Interface: A Perspective on Clinical Needs and Challenges.
Article in Biomedical materials & devices (New York, N.Y.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Skin-related complications are among the most common secondary conditions experienced by lower limb amputees. Besides connecting the prosthetic legs, the residual limb-socket interface (RLSI) plays a crucial role in maintaining skin health for prosthesis users. However, RLSI evaluation typically relies on subjective feedback from amputees, who may have difficulty accurately assessing the condition of the interface-particularly those with sensory impairments. RLSI monitoring systems have the potential to improve care by providing objective, real-time, and quantitative feedback to amputees, prosthetists, and clinicians. Despite advancements in sensing technologies, most RLSI monitoring research has focused on technical development, with limited attention to clinical integration. As a result, there is a lack of clinical evidence demonstrating improved outcomes from using these monitoring systems. This perspective aims to help researchers align their sensing technologies with current clinical practices so that RLSI monitoring data can support evidence-based medical decision-making. We begin by reviewing RLSI manufacturing and maintenance procedures, followed by an overview of common clinical strategies used to optimize RLSI performance. Next, we discuss the challenges of incorporating RLSI monitoring systems into existing clinical workflows. Finally, we identify key clinical needs and highlight several promising monitoring technologies that could address those needs.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.